INVO Fertility, Inc. (NASDAQ:IVF) — Market Cap & Net Worth
Market Cap & Net Worth: INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. (NASDAQ:IVF) has a market capitalization of $13.23 Million ($13.23 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26180 globally and #5235 in its home market, demonstrating a -12.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INVO Fertility, Inc.'s stock price $1.90 by its total outstanding shares 6961095 (6.96 Million). Analyse INVO Fertility, Inc. (IVF) cash conversion ratio to see how efficiently the company converts income to cash.
INVO Fertility, Inc. Market Cap History: 2025 to 2026
INVO Fertility, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $5.24 Million to $13.23 Million (0.00% CAGR).
INVO Fertility, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INVO Fertility, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IVF by Market Capitalization
Companies near INVO Fertility, Inc. in the global market cap rankings as of May 4, 2026.
Key companies related to INVO Fertility, Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
INVO Fertility, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, INVO Fertility, Inc.'s market cap moved from $5.24 Million to $ 13.23 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.23 Million | +152.46% |
| 2025 | $5.24 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of INVO Fertility, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.23 Million USD |
| MoneyControl | $13.23 Million USD |
| MarketWatch | $13.23 Million USD |
| marketcap.company | $13.23 Million USD |
| Reuters | $13.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more